Guided Therapeutics, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $63.0K | $388.0K | $591.0K | $2.3M | $643.0K | $182.0K | $899.0K | $0 |
| Accounts Receivable | $4.0K | $3.0K | $7.0K | $6.0K | $46.0K | — | — | — |
| Inventory | $448.0K | $633.0K | $632.0K | $548.0K | $571.0K | $605.0K | $48.0K | $114.0K |
| Total Current Assets | $605.0K | $1.2M | $1.4M | $3.0M | $1.6M | $896.0K | $1.0M | $196.0K |
| Property, Plant & Equipment | $16.0K | $23.0K | $32.0K | $42.0K | $14.0K | $1.0K | $0 | $21.0K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $1.3M | $1.4M | $1.7M | $3.4M | $2.0M | $1.4M | $1.2M | $236.0K |
| Liabilities | ||||||||
| Accounts Payable | $2.4M | $2.1M | $2.0M | $2.2M | $2.4M | $2.4M | $2.9M | $3.0M |
| Total Current Liabilities | $6.6M | $6.2M | $4.8M | $4.9M | $5.7M | $9.0M | $12.4M | $11.0M |
| Long-Term Debt | — | — | — | $0 | $22.0K | $23.0K | $0 | $5.1M |
| Total Liabilities | $7.3M | $6.3M | $5.5M | $6.2M | $7.5M | $12.2M | $18.1M | $16.1M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-157.1M | $-153.7M | $-151.1M | $-147.4M | $-142.4M | $-140.0M | $-139.6M | $-137.6M |
| Total Stockholders' Equity | $-6.0M | $-4.9M | $-3.8M | $-2.9M | $-5.4M | $-10.9M | $-16.9M | $-15.8M |